報價延遲最少15分鐘:2025/01/11 11:20 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.65 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.23/-0.32
|
|
企業價值
51.13M
|
| 資產負債 |
|
每股賬面淨值
0.12
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.90M
|
|
每股收益
0.12
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/11 11:20 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1. |